Concepedia

Alan M. Rapoport

AM

Statistics

Publications

80

Citations

5.5K

H-Index

40

Active since

1972

Affiliations

New England Institute for Neurology and Headache(Current)

University of California, Los Angeles

Albert Einstein College of Medicine

Yale University

New York Medical College

Alan M. Rapoport is an author at New England Institute for Neurology and Headache specializing in headache disorders, headache management, and migraine pharmacotherapy.

ORCID

Publications per year

1972–2024

80

Publications

80

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

Tony W. Ho, L. K. Mannix, Xiaoyin Fan et al. · Neurology · 2007 · 465 citations

, , +17

Efficacy of Gabapentin in Migraine Prophylaxis

Ninan T. Mathew, Alan M. Rapoport, Joel R. Saper et al. · Headache The Journal of Head and Face Pain · 2001 · 341 citations

, , +16

Migraine Prophylaxis With Divalproex

N. T. Mathew, Joel R. Saper, Stephen D. Silberstein et al. · Archives of Neurology · 1995 · 327 citations

, , +15

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, David W. Dodick, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 285 citations

, , +8

Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study

Marcelo E. Bigal, Lars Edvinsson, Alan M. Rapoport et al. · The Lancet Neurology · 2015 · 260 citations

, , +9

1–5 of 80